150 material Form 8-K filings that 135 companies we cover made with the SEC in February 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Arlo Technologies appointed Chief Financial Officer Kurt Binder as its Chief Operating Officer, effective February 28, 2024, adding the role to his existing CFO duties. He received a performance-vesting award of 600,000 RSUs tied to growth in cumulative paid subscribers, which would dilute shareholders only if the milestones are reached.
Kurt Binder, 53, named Chief Operating Officer effective February 28, 2024; he remains CFO, a role he has held since September 26, 2022.
Board committee approved the appointment on February 2, 2024; the company announced it February 29, 2024.
Award of 600,000 performance-vesting RSUs, vesting in three equal installments at 1, 2 and 3 million incremental Cumulative Paid Subscribers over audited year-end 2023 levels, with a five-year deadline per level.
Binder previously was CFO of CalAmp Corp. and CFO of VIZIO, Inc.
William Seeger, a director of ICU Medical, resigned from the company's board and its Audit and Compliance Committee effective immediately, as Smiths Group's nominated director, in anticipation of his retirement from the Smiths Group board on May 31, 2024. The filing states the resignation did not result from any disagreement with the company or any matter relating to its operations, policies or practices, and that Smiths Group keeps the right to designate a board member while it owns at least 5% of the company's common stock.
William Seeger resigned from the ICU Medical board and Audit and Compliance Committee, effective immediately
Seeger's resignation is tied to his planned retirement from the Smiths Group plc board on May 31, 2024
The filing states no disagreement with the company or matter relating to its operations, policies or practices
Smiths Group may keep designating a board member while it owns at least 5% of ICU Medical common stock, per the January 6, 2022 Shareholders Agreement
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.